Agreement No.: UMO-2020/39/B/NZ7/01913Research and Development Agreement • October 11th, 2021
Contract Type FiledOctober 11th, 2021• development of methodologies of encapsulation of neuroprotectants and contrast agents (fluorescent and MRI) adjusted to their physicochemical properties, for the formation of nanocarriers with the size in the range (10 - 150 nm) with surfaces functionalized for targeted delivery;
Agreement No.: UMO-2020/39/B/NZ7/01913 Title: New generation teranostatic nanocarriers for detection, diagnosis and neuroprotective treatment of ischemic stroke brain damageResearch and Development Agreement • October 11th, 2021
Contract Type FiledOctober 11th, 2021• development of methodologies of encapsulation of neuroprotectants and contrast agents (fluorescent and MRI) adjusted to their physicochemical properties, for the formation of nanocarriers with the size in the range (10 - 150 nm) with surfaces functionalized for targeted delivery;